Question-and-Answer Session
Operator
Thank you (Operator Instructions) Our first question comes from Mr. Imron Zafar from Deutsche Bank. Sir your line is open.
Imron Zafar - Deutsche Bank
Hi good afternoon thanks for taking question. My first question is on the Prodesse H1N1 testing, can you just explain what the utility of this would be, how will it be used? In other words right now if you are suspected to have H1N1 and you test positive for influenza A or you're pretty much given Tamiflu. How do you see this test being used going forward?
Eric Tardif
Hi Imron, this is Eric Tardif. First of all the protocol that we see being used and we think that clinicians are going to adopt is to first screen with the ProFlu+ test which as you indicated would detect the presence of H1N1 if it's there. And subsequently if there is a desire to sub-type in to figure out whether the flu is in fact H1N1, to run the prove ProFlu-ST which is the sub typing assay. The utility comes very simply from the fact that there is an increasing to know what flu strain is present because some of them do respond to antivirals and others do not.
Imron Zafar - Deutsche Bank
Okay and then just on the Prodesse asset again, so you talked about 15 million in revenues in 2010. Herm, can you just talk about the seasonality of this business, how we should think about it for modeling purposes for 2010 and beyond? And then Carl maybe just give us a little bit of peek into the pipeline of this --
Herm Rosenman
Imron it's early days for us and we are not all that familiar with the business. Obviously we are talking about flu here, so it probably has some seasonality but, at this point we're certainly not going to give 2010 guidance but nice try.
Carl Hull
Yeah Imron, I would add to that by saying that I think all bets are off in terms of previous patterns the seasonality of flu test and products of all kinds, things are obviously happening today that are very different than historical patterns. And having been the owner of the business for what seven working days now, I don't think any of us want to, how it goes as to how that seasonality is actually going to pan out. We're doing everything we can obviously to maximize the immediate opportunity that's in front of us and I think based on the initial feedback from our sales team that opportunity is a robust one.
- To read the full transcript on Seeking Alpha, click here »
